{"id":15521,"date":"2026-02-13T16:25:09","date_gmt":"2026-02-13T15:25:09","guid":{"rendered":"https:\/\/www.cbd.fr\/blog\/?p=15521"},"modified":"2026-02-13T16:25:10","modified_gmt":"2026-02-13T15:25:10","slug":"cbd-and-epilepsy-where-does-scientific-research-stand","status":"publish","type":"post","link":"https:\/\/www.cbd.fr\/blog\/en\/cbd-and-epilepsy-where-does-scientific-research-stand\/","title":{"rendered":"CBD and epilepsy: where does scientific research stand?"},"content":{"rendered":"

The use of CBD in the treatment of epilepsy<\/strong> is currently generating as much hope as it is questions. For several years, scientific studies and clinical trials<\/strong> have been investigating the potential of phytocannabinoids derived from hemp<\/strong> to reduce the frequency of seizures<\/strong>, particularly in certain rare and severe forms of epilepsy<\/strong>. Research is progressing rapidly, but all aspects of CBD’s efficacy<\/strong>, its potential side effects<\/strong> , and its place in treatment protocols for adults and children remain to be clarified. Let’s explore together the current state of medical knowledge on this sensitive topic.<\/p>\n\n

<\/h2>\n

Understanding Epilepsy and its Therapeutic Challenges<\/strong> Epilepsy encompasses a range of neurological disorders characterized by recurrent seizures due to abnormal electrical activity in the brain. While some patients respond well to<\/strong>conventional anti-epileptic drugs , nearly a third have<\/strong>refractory epilepsy<\/p>\n

, resistant to conventional treatments. <\/strong> This reality necessitates a constant search for new solutions to improve the quality of life for those affected. In children with syndromes such as Dravet or Lennox-Gastaut, the complexity of severe forms makes daily management particularly difficult. This context explains why the potential of CBD is attracting so much attention from both the scientific and advocacy communities involved in epilepsy. How does CBD affect epilepsy?<\/strong>Cannabidiol (CBD) is a non-psychoactive compound extracted from hemp. Unlike THC<\/a>, it does not produce a high, but interacts with various receptors of the endocannabinoid system present in our bodies. According to current research, this interaction could help modulate neuronal activity and regulate the hyperexcitability responsible for epileptic seizures. Advances in<\/strong> The use of CBD for epileptic seizures demonstrates the strong interest in this compound as an alternative therapeutic approach, supported by analyses from various clinical studies. These studies also suggest that CBD influences different<\/strong> neurochemical circuits involved in the transmission of electrical signals.<\/p>\n\n

<\/h2>\n

Its exact role remains to be precisely defined, but interest in these mechanisms is growing as the results of<\/strong> clinical trials accumulate, particularly in children suffering from<\/strong> rare forms of epilepsy. <\/strong> What are the main hypotheses being investigated? The research explores several potential mechanisms of action of<\/strong>cannabidiol:<\/p>\n

Modulation of ion channels<\/a> that participate in neuronal excitability Inhibition of pro-convulsant substances<\/strong>in the brain Anti-inflammatory effect of CBD<\/strong> on brain tissue None of these avenues has been fully confirmed, but each contributes to a better understanding of the range of possible<\/strong>neuroprotective properties of CBD<\/p>\n\n

\n
\n

Sommaire<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n